Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

FDA approval of controversial Alzheimer's drug could delay discovery of more promising treatments

By Étienne Aumont, Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
Marc-André Bédard, Professor of cognitive pharmacology, Université du Québec à Montréal (UQAM)
Share this article
The new drug is based on the idea that a build-up of amyloid in the brain leads to the disease. But that hypothesis has been under scrutiny lately.


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter